Search

everythinglearnresearchcommunity

for

Search:↓

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Tangent screens help detect visual field defects from vigabatrin.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Valproic acid is a more effective treatment for vomiting in Alexander disease than other medications, with few side effects.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Certain medications can cause serious side effects, so it's important to report them.

Topical calcitriol may reduce hair loss from chemotherapy at higher doses.

Topical calcitriol is safe for preventing hair loss during chemotherapy.

Oral difelikefalin significantly reduces itch in notalgia paresthetica.

The document concludes that fexofenadine reduces inflammation in chronic hives, cholestyramine helps half of pregnant women with itchy rashes, and relaxing incisions are a good alternative in facial surgery for the elderly.

Disodium folinate can safely and effectively replace calcium folinate in colorectal cancer treatment.

Topical calcitriol (BPM31543) is safe for preventing hair loss from chemotherapy and shows some effectiveness.

Both steroids, especially cyproterone acetate, harm quail's vital organs.

Topical calcitriol appears safe and may reduce hair loss during chemotherapy.

A certain medication improved severe itching in a boy with liver and bowel disease by reducing histamine levels, suggesting a new treatment target.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

Ivacaftor can protect against noise-induced hearing loss by reducing oxidative stress.

Finasteride blocks deoxycorticosterone's anticonvulsant effects in infant rats, but indomethacin doesn't.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

Over 30 potential cancer prevention treatments are being tested, with some showing promise in early research.

Cinacalcet may help treat hereditary vitamin D resistant rickets safely.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

Avemar may help in cancer treatment, but its effectiveness isn't proven yet.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.

Enfortumab vedotin can cause skin issues, especially in older males, needing early monitoring.